Dolores Hernández‐Maraver

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer et al. · Journal of Clinical Oncology · 2012 · 441 citations · Full text

PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT.

Beatriz Rodríguez‐Vigil, Nieves Gómez León, Inmaculada Pinilla et al. · PubMed · 2006 · 137 citations

Lesion Detection, Oncologic Imaging, Pet-mri +17

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

Holly L. Geyer, Robyn M. Scherber, Amylou C. Dueck et al. · Blood · 2014 · 89 citations · Full text

Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab‐based regimens treatment?

Maria J. Garcia‐Rodriguez, Miguel Canales, Dolores Hernández‐Maraver et al. · American Journal of Hematology · 2008 · 66 citations · Full text

Regimens Treatment, Immunology, Hepatitis B +17